top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Emerging Paradigms in Insulin Resistance
Emerging Paradigms in Insulin Resistance
Autore Burke Susan J
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (190 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato epicardial adipose tissue
hypertrophy of adipocytes
CAD severity
adipokines
insulin resistance
insulin-degrading enzyme
pancreas
liver
insulin receptor
glucose transporters
acute intermittent porphyria
carbohydrate loading therapy
hyperinsulinemia
fast-acting insulin
experimental liver-targeted insulin
hyperinsulinaemia
osteocalcin
beta-hydroxybutyrate
phenotype
stages
serotonin
glucagon-like peptide-1
glucagon
type 2 diabetes
hyperglycaemia
apoptosis
endoplasmic reticulum stress
glucosamine
pancreatic β-cell dysfunction
ovariectomy
raloxifene
Negr1
obesity
metabolic disease
metabolomics
glucose intolerance
genetic models
beta hydroxybutyrate
osteoporosis
fragility fractures
bone mineral density
osteocalin
vitamin D
collagen
hydroxyapatite
diabetes
inflammation
thiazolidinedione
ISBN 3-0365-5366-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910619471703321
Burke Susan J  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Autore Mager Hans-Jurgen
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (228 p.)
Soggetto topico Research & information: general
Soggetto non controllato hereditary hemorrhagic telangiectasia
rare diseases
telangiectasis
transforming growth factor-beta (TGF-β)
Smad pathway
gastrointestinal bleeding
epistaxis
nosebleeds
tacrolimus
nasal ointment
genetic disease
rare disease
hereditary hemorrhagic telangiectasia (HHT)
telangiectases
mechanical damage
sun-induced trauma
vascular malformations
Endoglin
activin-receptor-like kinase 1
Hereditary Hemorrhagic Telangiectasia
antithrombotic therapy
anticoagulants
antiplatelets
bleeding
safety
HHT
ALK1
endoglin
raloxifene
bazedoxifene
tranexamic acid
propranolol
FK506
etamsylate
N-acetylcysteine
pulmonary arteriovenous malformations
transcatheter embolotherapy
screening
guidelines
Hereditary hemorrhagic telangiectasia
pediatrics
genotype–phenotype correlation
arteriovenous malformation
ENG
ACVRL1
SMAD4
microRNA
biomarker
plasma
arteriovenous malformations (AVMs)
angiogenesis
activin receptor-like kinase 1 (ALK1)
transforming growth factor beta (TGF-β)
bone morphogenetic protein (BMP)
propranolol gel
epistaxis severity score
nasal endoscopy
antiangiogenic properties
non-coding RNAs
microRNAs
long non-coding RNAs
biomarkers
endothelial cells
hereditary hemorrhagic telangiectasia (HHT), second-hit
arteriovenous malformation (AVM)
Smad4
inflammation
shear stress
vascular injury
somatic mutation
cell adhesion
vascular endothelial growth factor (VEGF)
telangiectasia
hereditary hemorrhagic
survival
life expectancy
pulmonary arteriovenous malformation
contrast enhanced magnetic resonance angiography
liver
MRI
ultrasound
AVM
bevacizumab
Osler–Weber–Rendu
hereditary hemorrhagic telangiectasia/HHT/osler’s disease
cerebral ischemic lesions
catheter based embolization therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Hereditary Hemorrhagic Telangiectasia
Record Nr. UNINA-9910557578003321
Mager Hans-Jurgen  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui